Author: therawinformant

  • 4 excellent ASX growth shares to buy in FY 2021

    ASX growth shares

    If you have space in your portfolio for some growth shares, then I think the ones listed below could be well worth considering.

    Here’s why I think these ASX growth shares are quality options:

    Bubs Australia Ltd (ASX: BUB)

    The first ASX growth share to consider buying is Bubs. It is a goat’s milk-focused infant formula and baby food company which I believe could grow materially in the future. This is thanks to its growing distribution footprint online in China and offline in Australian supermarkets and pharmacies. Another big positive is its recent expansion into cow’s milk infant formula.

    Nearmap Ltd (ASX: NEA)

    Another ASX growth share to buy is Nearmap. It is a leading aerial imagery technology and location data company. In FY 2020 the company expects to report annualised contract value (ACV) of $103 million to $107 million. This compares to $90.2 million in FY 2019. Whilst this is a large number, it is still only a fraction of the global aerial imagery market estimated to be worth US$10.1 billion in 2020.

    Pushpay Holdings Group Ltd (ASX: PPH)

    Pushpay is another growth share I would buy. It is a donor management platform provider for the faith sector. Pushpay has been growing at a rapid rate in recent years thanks to its leadership position in a niche but lucrative market. Pleasingly, this growth looks set to continue in the coming years with management aiming to win a 50% share of the medium to large church market in the future. This represents a US$1 billion revenue opportunity and is many times FY 2020’s revenue of US$127.5 million.

    ResMed Inc. (ASX: RMD)

    A final growth share to consider buying is ResMed. I think the sleep treatment-focused medical device company can grow very strongly over the next decade thanks to its industry-leading products and sizeable market opportunity. Management estimates that there could be upwards of 1 billion people impacted by sleep apnoea worldwide. The vast majority of these are currently undiagnosed.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nearmap Ltd. and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of and has recommended BUBS AUST FPO. The Motley Fool Australia has recommended Nearmap Ltd., PUSHPAY FPO NZX, and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 4 excellent ASX growth shares to buy in FY 2021 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30hSuWC

  • Why these are the top performing ASX 200 shares over the past year

    cards spelling out top 5 pegged to a rope

    The S&P/ASX 200 (ASX:XJO) is down nearly 10% from this time a year ago. In that time we’ve seen drought, bushfires, and COVID-19. But not all ASX share prices have been beaten down by current events. On that note, let’s take a look at the 5 top performing shares in the ASX 200 over the past year. 

    Afterpay Ltd (ASX: APT)

    The Afterpay share price is up 189% over the past year. The buy now, pay later (BNPL) provider saw investor confidence evaporate in March when its share price fell to a low of $8.90. But demand for Afterpay’s payment solution continued to grow as the pandemic took hold. This saw the Afterpay share price rise 672% from its March low to trade at $68.69 currently. 

    Afterpay has reported underlying sales of $11.1 billion in FY20, more than double the prior corresponding period. Underlying sales in 4Q FY20 were $3.8 billion, up 127% on Q4 FY19. This was the highest quarterly performance ever, reflecting the accelerating shift to eCommerce spending as a result of the effects of COVID-19. 

    Active customers grew to 9.9 million in the fourth quarter, 116% above FY19 which exceeded Afterpay’s target of reaching 9.5 million customers by the end of FY20. This included 5.6 million customers in the United States, 1 million United Kingdom customers, and 3.3 million customers in Australia and New Zealand. Growth in customer numbers reflects the flight to online spending and attractiveness of Afterpay’s budget-focused business model in the current environment. 

    Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) 

    The Fisher & Paykel Healthcare share price has gained more than 130% over the past year. The healthcare company’s role in fighting COVID-19 largely insulated its share price during the March bear market, and it has gone from strength to strength since. Fisher & Paykel announced record results for the year to 31 March 2020. Operating revenue increased 18% to $1.26 billion and net profit after tax rose 37% to $287.3 million. 

    The increase in revenue was largely driven by growth in the use of Fisher & Paykel’s Optiflow nasal high flow therapy, demand for products to treat COVID-19, and strong hospital hardware sales. CEO Lewis Gradon said, “Beginning in January, demand for our respiratory humidifiers accelerated in a way that has been unprecedented. We managed to double, and in some cases triple, output for some of our hospital hardware products over just a few months.”

    For the first three months of FY21, Fisher & Paykel’s Hospital product group has continued to accelerate with hardware growth of 300%. Hospital consumables are tracking at over a one third increase. Based on current assumptions about the impact and duration of COVID-19, Fisher & Paykel Healthcare is forecasting FY21 revenue of $1.48 billion and net profit of $325 – $340 million. 

    Perseus Mining Limited (ASX: PRU) 

    The Perseus Mining share price is up nearly 122% over the past year. Although the share price dipped as low as 71 cents during the March correction, it has since recovered to $1.42. The miner has benefited from rising gold prices over the course of 2020, with the cost of an ounce of gold increasing from less than $2200 in January to nearly $2600 currently. The rise in the Persus Mining share price saw it join the S&P/ASX 200 in the most recent quarterly rebalance. 

    During the third quarter, the miner produced 57,983 ounces of gold from its two producing gold mines, Edikan in Ghana and Sissingue in Cote d’Ivoire. An average sales price of US$1,491 was achieved with an all-in site cost of US$1,083 per ounce. Perseus Mining reported a cash and bullion balance of US$162 million at the end of the March quarter. Significant progress was made on the Yaoure Gold Mine in Cote d’Ivoire during the quarter, with works to enable the first pour of gold at the mine by December generally on schedule. 

    Mesoblast limited (ASX: MSB) 

    The Mesoblast share price has climbed more than 130% over the past year as the regenerative medicine company benefits from its work combatting COVID-19. The share price dropped to a low of $1.10 in the March market correction but has since recovered to $3.36. Its surging share price has seen Mesoblast join the ASX 200 in the most recent quarterly rebalance. 

    Mesoblast’s product remestemcel-L is undergoing phase 3 trials to assess its use in treating adult COVID-19 patients with acute respiratory distress syndrome. The product is also available in the United States for compassionate use for child COVID-19 patients with cardiovascular and other complications of multisystem inflammatory syndrome. 

    During the nine months to 31 March 2020, Mesoblast reported a 113% increase in revenues which reached $31.5 million, up from $14.8 million in the prior corresponding period. Loss after tax reduced to US$45.3 million for the first nine months of FY20, compared to a loss of US$69.1 million for the first nine months of DY19. Cash on hand at 31 March was $60.1 million with an additional US$90 million capital raised in May 2020. 

    Megaport Ltd (ASX: MP1) 

    The Megaport share price is up just over 100% from this time a year ago. Shares in the technology company took a dive in March, falling from a February high of $12.37 to a low of $6.74. Now trading at $13.69, the increase in the Megaport share price saw this company also join the ASX 200 in the recent rebalance. 

    Magaport operates in the network-as-a-service space, providing bandwidth which allows users to connect to cloud services and data centres. Now operating in 21 countries, Megaport boasts customers including Amazon, Moody’s, Facebook, Mastercard, and Fedex. The technology company has been recording high growth rates in key financial metrics, with revenue growing 10% quarter-on-quarter in March. Monthly recurring revenue increased 19% in the March quarter to $5.4 million. 

    Megaport plans to expand its sales team to access greater market share. An additional $66 million capital was raised in April with funds earmarked for sales acceleration, product development, and platform expansion. A high growth but cash burning company, Megaport has shored up its balance sheet to allow it to fund future strategic opportunities in the high growth cloud services space.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Kate O’Brien has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of MEGAPORT FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended MEGAPORT FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why these are the top performing ASX 200 shares over the past year appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/38XncYJ

  • Leading brokers pick the latest ASX 200 stocks to buy today

    Hand writing Time to Buy concept clock with blue marker on transparent wipe board.

    The S&P/ASX 200 Index (Index:^AXJO) is taking off again as rising commodity prices and renewed hope for a COVID-19 vaccine lifted sentiment.

    The top 200 stock benchmark jumped 1.2% to over 6,000 points during lunch time trade with the Rio Tinto Limited (ASX: RIO) share price and Fortescue Metals Group Limited (ASX: FMG) share price doing the heavy lifting.

    But there’s value to be found outside of the miners and top brokers have listed their latest ASX buy ideas.

    Rising tide lifting this ship

    The Austal Limited (ASX: ASB) share price jumped 2% to $3.30 at the time of writing after Citigroup reiterated its “buy” recommendation on the stock.

    The shipbuilder is a hot pick even though it wasn’t picked by the US Navy to build the next-gen guided-missile frigates FFG(X).

    But never say never. While Austal lost out on the original tender, Citi reckons it could get a second bite of the cherry if the US decides to appoint a second builder.

    Second chance

    Such a move makes sense as it will allow the Navy to commission more ships more quickly. It can also achieve economies of scale while putting downward pressure on costs by including a bit of competition to the program.

    “However, even if this does not eventuate, there appears to be plenty of work to go around in the US, and the Navy appears to be considering the production capacities of its shipbuilders in order to maintain its industrial base,” said Citi.

    The broker’s 12-month price target on Austal is $4.23 a share.

    Melbourne lockdown priced in

    Meanwhile, the Premier Investments Limited (ASX: PMV) share price dipped 0.3% to $16.09 during lunch. Investors are fretting over the impact of the second Victorian coronavirus lockdown on the retail group.

    But Macquarie Group Ltd (ASX: MQG) aren’t worries and repeated its “outperform” recommendation on the stock.

    The broker estimated that 19% of the group’s Australian store network is temporarily closed due to what’s happening in Melbourne. This represents 13% of its global store network and poses a risk to Premier’s earnings if online sales and growth in other states do not offset the loss.

    Premium buy at discount price

    Even if that was the case, the stock looks cheap. Macquarie estimates that its trading at a 40% discount to peers like Lovisa Holdings Ltd (ASX: LOV) and City Chic Collective Ltd (ASX: CCX).

    Macquarie’s 12-month price target on Premier is $20.11 a share.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Austal Limited. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Leading brokers pick the latest ASX 200 stocks to buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3j5IZCo

  • Instantly diversify your portfolio with these quality ASX ETFs

    world economic outlook

    I believe that having a diversified portfolio is very important.

    For example, if your portfolio was concentrated on travel and bank shares, the value of your portfolio would be down materially this year.

    Whereas by spreading your investments across a number of sectors (and even geographies), your portfolio would be in much better shape.

    The good news is that thanks to exchange traded funds, diversification isn’t that hard to achieve with ASX shares.

    Two options for investors to consider for international diversification are listed below:

    Betashares Nasdaq 100 ETF (ASX: NDQ)

    The first exchange traded fund to consider buying is the Betashares Nasdaq 100 ETF. It gives investors exposure to the 100 largest non-financial companies on the NASDAQ exchange. These includes household names such as Amazon, Apple, Costco, Microsoft, Netflix, Starbucks, and Google parent, Alphabet.

    Given how the majority of companies in the fund have very positive outlooks I feel the exchange traded fund offers strong potential returns as well as diversity. As a result, I think it would be a great long term investment option.

    BetaShares Asia Technology Tigers ETF (ASX: ASIA)

    Another BetaShares exchange traded fund to consider buying for diversity is the Asia Technology Tigers ETF. This exchange traded fund gives you access to some of the most exciting technology companies in the Asian market. These include search engine company Baidu, ecommerce stars Alibaba and JD.com, and WeChat owner Tencent Holdings.

    As these companies are revolutionising the lives of billions of people in the region, I believe they are well-positioned for growth in the future. In light of this, as with the Nasdaq 100 ETF, I believe there’s a strong probability the BetaShares Asia Technology Tigers ETF will outperform the ASX 200 in the future. This could also make the fund a great buy and hold option for ASX investors.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of BETANASDAQ ETF UNITS. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool Australia has recommended BETANASDAQ ETF UNITS. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Instantly diversify your portfolio with these quality ASX ETFs appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2CaplEs

  • What history tells us about investing through COVID

    I received a message the other day. It was a question for the Motley Fool Money podcast.

    But, as I started to think about how I’d reply, I decided it was a topic that deserved a longer form treatment.

    Here’s the question:

    —-

    Hey Scott,

    If you could send a message to your (not much) younger self, what would you say? 

    (It’s been a bit tough for a young fella like me at the moment, I need you to pump me up a bit.)

    I’ve been having a rough run over the past few weeks, (not just with the stock market) and it’s kinda thrown me off.

    How can I push through, not just to make money… but to like be here for the long haul?

    Zac

    —-

    Zac, I hear you. I know how you feel. I’ve been there before.

    Here’s my response — not just for you, but for anyone who’s feeling that way.

    I’ve been doing this job for a long time.

    I’ve been investing for a lot longer.

    Which gives me an advantage.

    See, time is a wonderful thing. It gives you perspective.

    To be sure, you can get it from history. And that’s valuable.

    But there’s nothing like actually living through events to teach you some lessons.

    It seems strange to say, now, but at some future point we’ll forget most of the events of this current COVID crisis.

    Of course we’ll remember the pandemic. We’ll remember those whose lives were lost and changed.

    And we’ll remember the health, social and economic consequences.

    But most of us will remember it almost in the abstract. And we’ll forget most of the detail.

    Take political, geographic and economic circumstances of the past 40 years.

    I vividly remember the 1987 stock market crash. When I recall it, my first memory is the awful reporting of stockbrokers literally jumping out of windows.

    I remember people were worried. Scared. Frantic.

    But I can’t really recall those actual feelings, I just know that they were there.

    Fast forward to the dot.com crash. The stories of the NASDAQ’s soaring valuations before an almighty crash that took many, many years for that index to regain.

    I remember it all. I owned a couple of Australian technology companies whose shares never recovered (they were bought out, merged or changed business operations).

    But I can no longer recall the visceral feelings. I just have memories of feeling that way.

    And the same in the GFC.

    I remember hearing a radio report — perhaps on ABC Radio National, I think — of the mortgage stress and mounting foreclosures in the US. I remember my portfolio being hammered in the aftermath.

    Again, though, the memories are clinical, as if looking at someone else going through them.

    I’ll never give birth, and I don’t claim to know what it’s like, but I’m told the human body deals with labour the same way — of course women remember the experience, but apparently the mind dulls the strength of those memories, otherwise a second (and subsequent) pregnancy would never happen.

    But I think there’s another reason for all of this.

    In each case, while the events themselves are traumatic in the moment, our brains manage to subconsciously help us put those events into perspective.

    There is the joy of motherhood, for example, and all of the aggregate experiences that make up the full picture, of which labour, though sometimes traumatic, is only a part.

    Moving back onto ground I can write more confidently about (and with first hand knowledge of), the crashes of 1987, 2000 and 2008/9 are made less painful by the knowledge that the market recovered.

    And by perspective.

    Remember Grexit?

    It was all the papers could write about for months. It was going to be a global economic armageddon.

    Remember the PIIGS economies that were going to wreck Europe?

    Remember Brexit?

    Remember the Chinese ‘hard landing’ when the country was supposed to run out of foreign exchange?

    For many of you, the answer to some of those questions will be a straight out ‘no’.

    Which tells you something.

    For others, the memory will be strong. 

    So let’s delve into it. 

    At the time, nothing else mattered. Anyone who was anyone was reporting on it, talking about it, and trying to work out how it’d affect their portfolios.

    It’s worth noting a few things:

    First, most of them didn’t happen.

    Second, the one that did wasn’t the end of the world.

    Third, the biggest economic calamity of the past decade, COVID, was a ‘black swan’ that no-one saw coming even weeks before it hit.

    At the time, all of these potential or actual outcomes seem scary.

    Humans always overemphasise current events.

    And we struggle to see the bigger picture.

    COVID is bad.

    It’s terrible. It carries human and economic costs that are both awful.

    And yet..

    Without downplaying the impact, remember what’s happened since 1900.

    We had two world wars, for starters.

    Millions of people died. A tragic, unnecessary waste of human life.

    In that context, the stock market is a trifle.

    But, as a finance company, and as an investment adviser, it’s my job to remind you that the world, the economy and the markets rebounded incredibly from those seismic events.

    That’s what I mean about history and context.

    Could this time be different? Of course it could.

    Is it likely?

    I don’t think so.

    Why?

    History.

    Not just the history that says the market has always rebounded.

    But also the history of smart, thoughtful, well-meaning people who kept saying it was ‘different this time’.

    Steve Keen is still waiting, decades later, for his house price collapse.

    We’re more than a decade on from the ‘sky is falling’ predictions of the end of ‘fiat currency’ (government-backed dollars, Yen and Sterling).

    At the time, overwhelmed with ‘now’ and with not enough emphasis on either history or future, those people could only see the problems.

    In hindsight, we know the fears were overblown and overly fixated.

    I’m not going to downplay either the human or economic toll of COVID-19.

    I’m not going to downplay the policy challenges confronting doctors, economists, business people or politicians.

    I’m not going to be Pollyanna and refuse to acknowledge the problems and the risks.

    But I am going to say, with the benefit of history, that I have a very, very high level of confidence that we will get through this.

    We will deal with this.

    That there will be tragedy and loss, but that we will overcome.

    We got through two World Wars. Numerous other wars and conflicts.

    We got through existential crises like the Cuban Missile Crisis and decades of Cold War

    We got through economic crises like oil shocks, many recessions and a Great Depression.

    In the last 40 years, we got through stagflation, the 1987 market crash, the Asian Financial Crisis, the dot.com crash, and the GFC.

    You think this is the one that stumps us?

    You think this is the one we don’t recover from?

    You think this is how it ends?

    Cool. You’re welcome to that view.

    But good luck sitting on one end of the see-saw, with the weight of history on the other side.

    The recovery will be bumpy. We’ll have setbacks. It’ll seem dark, from time to time, perhaps even often.

    And there is no avoiding the awful human toll. COVID won’t discriminate. We will lose people, and we will lose jobs.

    But the economy will recover. 

    Because democratic capitalism is an unstoppable force.

    Yes, that might be an article of faith, except that faith requires a belief in the unseen.

    We’ve seen this movie before. We know how it almost certainly ends.

    Stay the course, Zac. Keep your chin up.

    Fool on!

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Scott Phillips has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post What history tells us about investing through COVID appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2CDOSFT

  • Amplia Therapeutics share price up 16% in 2 days as former Macquarie CEO takes substantial stake

    Buy shares

    The Amplia Therapeutics Ltd (ASX: ATX) share price is up 16.67% since Tuesday’s open to 14 cents per share, as former Macquarie Group Ltd (ASX: MQG) CEO Allan Moss announced that he had become a substantial holder.

    What was in the announcement?

    According to the announcement, former Macquarie CEO Allan Moss now owns 8.69% of Amplia Therapeutics through an investment company he controls called Blueflag Holdings. The company purchased 7,500,000 shares for $750,000, paying 10 cents per share. 

    Allan Moss was one of the founders of Macquarie Group and is known for his skill in choosing investments.

    Who else is buying Amplia Therapeutics shares?

    Also announced on Tuesday was that fund manager Platinum Asset Management had increased the size of its substantial holding in Amplia Therapeutics. This followed an institutional entitlement offer by the company. Platinum Asset Management increased its holding from 8.60% to 19.89%. The fund manager bought 11,454,000 shares for $1,145,400. The purchase price was 10 cents per share. 

    Amplia Therapeutics director, Dr Warwick Tong, also  participated in the institutional entitlement offer, purchasing 200,000 shares at $0.10 per share.

    About the Amplia Therapeutics share price

    Amplia Therapeutics is a biotechnology company with a pipeline of treatments for cancer and fibrosis. Its treatments work by inhibiting the spread of  affected cells throughout the body. The company is focused on ovarian and pancreatic cancer.

    Earlier in July, Amplia Therapeutics announced that it planned to raise $4 million at a price of 10 cents per share. The company also raised $930,000 in January.

    The company is raising capital to move toward a phase 1 trial of its AMP945 treatment. This is the company’s leading FAK inhibitor, which works by stopping cells from spreading when they are affected by cancer or fibrosis. According to the company, it is on the cusp of transforming into a clinical-stage company. The company plans to move towards a stage 2 trial in 2021. 

    For the year to the end of March 2020, Amplia Therapeutics had a loss after tax of $2,219,474. Its research and development expenses were $1,071,677, and general and administration expenses were $858,886.

    The Amplia Therapeutics share price is up 211% from its 52-week low of 4.5 cents per share. It has returned 141% since the beginning of the year. The Amplia Therapeutics share price is up 61% since this time last year.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Chris Chitty has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Amplia Therapeutics share price up 16% in 2 days as former Macquarie CEO takes substantial stake appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/308xIZe

  • Verizon Needs to ‘Step Up Our Work’ on Staff Diversity: CEO

    Verizon Needs to ‘Step Up Our Work’ on Staff Diversity: CEOJul.14 — Hans Vestberg, chairman and chief executive officer at Verizon Communications, discusses diversity within the company and their “Citizen Verizon” initiative, removing advertising from Facebook, and nations turning away from Huawei for 5G technology. He speaks on “Bloomberg Markets.”

    from Yahoo Finance https://ift.tt/3fFmSAk

  • Could The Market Be Wrong About Biogen Inc. (NASDAQ:BIIB) Given Its Attractive Financial Prospects?

    Could The Market Be Wrong About Biogen Inc. (NASDAQ:BIIB) Given Its Attractive Financial Prospects?It is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock has declined 17…

    from Yahoo Finance https://ift.tt/3gWBc80

  • Origin Energy share price flat on non-cash charge of $1.2 billion

    Power lines

    The Origin Energy Ltd (ASX: ORG) share price has remained relatively flat today, up 0.87% at the time of writing, following an announcement regarding non-cash charges. In FY20, the recognition of non-cash post-tax charges are expected to be between $1,160 million to $1,240 million.

    Origin Energy is a leading Australian energy retailer supplying customers with electricity, gas, LPG and solar.  

    What caused the charges?

    The key drivers of the charge have been attributed to revised commodity assumptions, economic impacts of the coronavirus pandemic, and the transition to lower carbon energy supply. 

    The estimates provided by Origin are subject to finalisation of its audited financial statements for FY20. 

    Because the estimates relate to non-cash charges, the charges will have no impact on Origin’s cash flow. The group confirmed it expects no change to its FY20 underlying earnings before interest tax depreciation guidance of $1.4–$1.5 billion.

    Origin CEO Frank Calabria said:

    Origin is well positioned over the long term with a business spanning energy retailing, power generation and natural gas which generates strong cash flow, along with exposure to future growth opportunities in renewable energy and new technologies. 

    FY21 update

    On 6 April, Origin released an operational and financial update. In the update, it assessed a range of options to reduce expenditure and help offset the impact of COVID-19 and lower oil prices. The group confirmed it is targeting a 25–30% reduction in capex in FY21, compared to previous guidance of FY20 capex of $530–$580 million. 

    Financial position

    On 31 December 2019, Origin Energy held liquidity of $3.8 billion. This consisted of $800 million in cash and $3 billion in omitted undrawn debt facilities. Its liquidity position is sufficient to meet upcoming debt of $1.2 billion maturing by December 2020 and $2 billion maturing in October 2021. 

    Origin’s net debt position was $5.6 billion as at 31 December 2019 and gearing was 29%.

    Commenting on Origin’s position amid the pandemic, Frank Calabria said, “[w]hile there is some uncertainty about the extent of the short term impact on Energy Markets, Origin is in a resilient financial position with a sound balance sheet and competitive cost position.”

    Revenue and profit was down 12% and 25%, respectively, when the group announced its half year report early this year in February. 

    The Origin share price is currently trading at $5.80 at the time of writing, which puts it up 0.87% today. Over the past year, the price has fallen 22.10%.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Matthew Donald has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Origin Energy share price flat on non-cash charge of $1.2 billion appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DAYOAy